Bassler Bonnie L reported grant involving 642 shares of Royalty Pharma plc at $58.41 for $37.5k on Sep 30, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Sep 30, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$37,496.33Shares × reported price
Shares traded
642Class A Ordinary Shares
Price per share
$58.41Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
79,823Direct
Trade date
Sep 30, 2026Grant
Filed
Sep 30, 2026, 4:33 PM ET0-day reporting delay
Accession
0001683607-26-000016Code A · Transaction 231873
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RPRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RPRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +5.2%1w ago −1.2%1d ago −0.2%
Returns since7d −2.7%30d +15%90d180d1y

Footnotes in full

F1: Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.